Latest news with #CLABSI
Yahoo
6 days ago
- General
- Yahoo
A&M students express concerns about housing on the Hill
NORMAL, Ala. (WHNT) — Alabama A&M University continues to grow, welcoming its largest-ever freshman class in both 2023 and 2024, but with growth comes challenges. The university has faced complaints from students and their families in recent years over student housing conditions. Now, A&M has to house more students than ever. Decatur Morgan Hospital achieves CLABSI infection rate of zero 'Sometimes the people who are in power in these situations don't fully understand the effects of what they're doing, especially when they don't fully consider the voices of the people that are under them,' said Alabama A&M student Georghetta Conaway. Conaway, a senior at A&M, has lived in university housing during her time on the Hill, but she said she needs to know if the school will still have a room for her next semester. She said she reached out to News 19 because she and other students have asked for information about where they will be able to live in August, and the university has been slow to provide it. 'My peers have said they've called the housing office and emailed and all those kinds of things, but nobody's really answering the phones for them,' Conaway said. According to a housing update sent to Conaway late Thursday, A&M confirmed it will prioritize on-campus housing for freshman students. When those campus rooms are full, upperclassmen will be directed to off-campus apartments leased by the university, which A&M said will be the available housing for more than 55% of their students. Body found on Whitesburg Bridge, death ruled as homicide Conaway is still not clear if students who use financial aid to help pay for housing will still be able to do that, or if they will face bigger out-of-pocket costs. 'They try to provide scholarships for people who may not look the best on paper, but they are trying to give our community, you know, everyone a chance at education,' Conaway said. 'I admire that and I appreciate that. I think of that when I think of this situation, but it also makes me upset because it feels like they're not planning properly to make sure they can accommodate all the people that they are letting into the school.' Conaway said she has felt discouraged from reaching out to A&M administration. She said she and her fellow students have questions and concerns that she hopes leadership will hear and provide timely responses moving forward. 'It also just feels like the money is not going to places where it would be in the best interest of their current students,' Conaway said. 'Because what is a school without students?' Alabama A&M currently has two dorms closed for renovations. Morris and Stephens Halls are scheduled to reopen in Spring 2026. News 19 has reached out to Alabama A&M for comment, but we have not heard back. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
National Post
27-05-2025
- Business
- National Post
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
Article content Article content MISSISSAUGA, Ontario — Covalon Technologies Ltd. (the 'Company' or 'Covalon') (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that exciting results from a clinical study evaluating the use of its VALGuard ® Vascular Access Line Guard will be presented at two notable scientific meetings in the fall and are advancing through the publication process in a well-regarded academic journal. Article content The study, conducted independent of Covalon, was a prospective pre- and post- intervention study of VALGuard ® across critical and acute care units focused on the reduction of Central Line-Associated Blood Stream Infections (CLABSIs). Article content 'Blood streams infections are a serious, but largely preventable complication that tragically affect hundreds of thousands of patients each year, with a mortality rate estimated at 15% to 20%,' said Dr. Kate Evely, Vice President of Clinical Affairs for Covalon. 'Major hospitals all over the United States are adding VALGuard ® as an important part of their infection prevention program's toolkit to protect intravenous lines from gross contamination, a known source of infection. The study results provide impactful real-world evidence on the use of VALGuard ®. The forthcoming publication of this investigator-initiated study is a testament to the dedication of the research team and our shared goal of advancing patient care.' Article content As the authors advance the study through the final stages of the peer review process toward publication, they look forward to presenting their findings to their peers at two prestigious scientific conferences this fall – September's Association for Vascular Access Annual Scientific Meeting, the premier platform for the latest innovations and emerging technologies in vascular access, followed by October's American Nurses Credentialing Center (ANCC) Magnet Pathway Conference, which attracts more than 11,000 nursing leaders and professionals from around the world. Article content About VALGuard VALGuard ® is a unique innovative transparent line guard designed to protect IV line connections and hubs from external contaminants, including body fluids, and secretions that can lead to serious, life-threatening blood stream infections. Article content About Covalon Covalon is a leading medical device company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website at Article content Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Article content This news release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as 'seek', 'anticipate', 'plan', 'estimate', 'expect', 'intend', or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might', 'will' or 'will be taken', 'occur', or 'be achieved'. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management's expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the 'Risks and Uncertainties' section of our management's discussion and analysis of financial condition and results of operations for the year ended September 30, 2024, which is available on the Company's profile at any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law. Article content Article content Article content Article content Article content
